10. Gallium PET

11. Metastatic Thyroid Ca. to Lung, Mediastinum, and Skeleton

17. CT: an indeterminant LUL nodule.

20. False Positives: Active Infection/Inflammation TB Pneumonia Cryptococcosis Histoplasmosis Aspergillosis Inflammatory

21. Staging

24. 60/M: Lung Ca.

25. 62y/o Lung Ca. with adrenal mass

28. Staging before resection of recurrent disease

29. 63 y/o woman with a H/O Colon Ca. and liver metastases

30. 79/M. Resection of Rectal Ca (Dukes B) 4 mos earlier,  CEA, CT: possible local relapse.

32. Sagittal Transverse Coronal

34. 58/M - S/P Colon Ca Rising CEA Coronal Coronal Transverse

35. 58/M - S/P Colon Ca Rising CEA Local recurrence Hemangioma

38. N. G. 8/15/00 Colon cancer with a Hx of UC Proven mesenteric carcinomatosis

39. 1756441

40. Huebner et al. J Nucl Med 2000;41:1177-1189

41. Huebner et al. J Nucl Med 2000;41:1177-1189

42. Colorectal Cancer: A possible algorithm CT evidence of resectable disease in patient suitable for surgery Whole Body PET imaging

43. Colorectal Cancer: A possible algorithm CT evidence of resectable disease in patient suitable for surgery Whole Body PET imaging Further evaluation of CT abnormality All sites negative

44. Colorectal Cancer: A possible algorithm CT evidence of resectable disease in patient suitable for surgery Whole Body PET imaging Further evaluation of CT abnormality Surgery All sites negative PET = CT and other sites negative

45. Colorectal Cancer: A possible algorithm CT evidence of resectable disease in patient suitable for surgery Whole Body PET imaging Further evaluation of CT abnormality Non-surgical management Surgery All sites negative + ve at multiple Sites PET = CT and other sites negative

46. 44/F with Colon Ca, S/P primary resection. CT: multiple liver mets and a lung nodule Treated with systemic chemoTx instead of intra-arterial chemoTx . Staging:

48. S/P ChemoRx

49. Before 2mo after Adjuvant chemo and radioTx Prior to surgery for rectal Ca.

53. 1846641 Lymphoma Before After 2 cylcles of Chemo

54. Lymphoma Before After 2 cylcles of Chemo

55. 56y/o : Lymphoma

56. Before 1 month after XRT

59. ( Choi et al: J Nucl Med 2000) Evaluation of N stage of patients with Esophageal Cancer: 48 patients underwent esohagectomy and lymph node dissection (2 field=35pts, 3 field=13pts)

60. Evaluation of metastases in Esophageal Cancer: CT versus PET CT PET Kole 1998 Lymph nodes 62% 90% Resectability 65% 88% Choi 2000 Lymph nodes 78% 86% N staging 60% 83% Luketich 1999 Distant mets 63% 84%

61. Rt. Paratracheal Subcarinal Lt. Gastric Common hepatic & Celiac Rt. Paratracheal Subcarinal Lt. Gastric Common hepatic & Celiac

62. 62F: Gastric Ca. S/P Resection CT: Recurrence PET performed to exclude other sites of tumor Ultrasound: confirmed a liver mets Surgery cancelled and the patient treated with Chemo

65. Before sagittal coronal After Radiochemo 49M: large squamous esophageal Ca. Echo-endoscopy – an enlarged node

67. 45M: S/P esophagectomy, Patient is clinically asymptomatic  alkaline phosphatase

69. Surviavl based on initial PET scan identification of distant versus local disease only: (Luketich et al: Ann Thorac Surg 1999;68)

71. 53/F: Pancreatic mass

72. 51F: CT: (1) Mass forming pancreatitis vs Cancer (2) Hepatic Hemangioma vs Metastasis Coronal Sagittal

73. Pancreatic Cancer: DDx: Chronic pancreatic mass vs. Cancer Delbeke et al: J Nucl Med 1999

75. High Grade Low Grade

76. Kim CK et al. J Neuro-Oncol 1991

79. I V M L FDG-PET I-131 Anterior Posterior M 2 Coronal slices

80. 62 y/o male S/P Resection of transglottic right laryngeal cancer R/O Recurrence

81. FDG PET Imaging Determination of the site of unknown primary tumor 20~30%

88. Coronal Sagittal

89. 55 y/o woman Dx’ed with colon ca. S/P resection 2 yrs ago CEA level is rising No evidence of recurrence. CT: normal .